| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 7 | 4 | |
| Improve mobility | 1 | 2 | |
| Optic nerve inflammation (optic neuritis) | 1 | 1 | |
| Speech problems | 1 | 2 | |
| Systemic lupus erythematosus | 1 | 3 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Abdominal bloating | 1 | |
| Flushing | 1 | |
| Insomnia | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 2 | |
| Moderate | 4 | |
| Mild | 1 | |
| None | 1 |